Cargando…
Medical Therapy for Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction (HFpEF) is a challenging disease state that has long been plagued by heterogeneity in diagnostic criteria and underlying etiologies. Due in part to the complexity of defining this disease and the simplistic approach of only studying medications that hav...
Autores principales: | Varnado, Sara, Ali, Hyeon-Ju Ryoo, Trachtenberg, Barry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Houston Methodist DeBakey Heart & Vascular Center
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733121/ https://www.ncbi.nlm.nih.gov/pubmed/36561091 http://dx.doi.org/10.14797/mdcvj.1162 |
Ejemplares similares
-
Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016) -
Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013) -
Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012) -
Personalized Management for Heart Failure with Preserved Ejection Fraction
por: Lin, Chang-Yi, et al.
Publicado: (2023) -
Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)